CoChat

Risk of Dementia in Long-Term Benzodiazepine Users: Evidence from a Meta-Analysis of Observational Studies

Open access
He, Qian, Chen, Xiaohua, Wu, Tang, Li, Liyuan, Fei, Xiaofan · 2019 · Journal of Clinical Neurology
Cited by 95

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Background and Purpose There is conflicting evidence in the literature on the association between benzodiazepines (BDZs) and the risk of dementia.This meta-analysis aimed to determine the relationship between the long-term usage of BDZs and the risk of dementia. MethodsThe PubMed and Embase databases were systematically searched for relevant publications up to September 2017.The literature search focused on observational studies that analyzed the relationship between the long-term use of BDZs and the risk of dementia.Pooled rate ratios (RRs) with 95% confidence interval (CI) were assessed using a random-effects model.The robustness of the results was checked by performing subgroup and sensitivity analyses. ResultsTen studies were included: six case-control and four cohort studies.The pooled RR for developing dementia was 1.51 (95% CI=1.17-1.95,p=0.002) in patients taking BDZ.The risk of dementia was higher in patients taking BDZs with a longer half-life (RR=1.16,95% CI= 0.95-1.41,p=0.150) and for a longer time (RR=1.21,95% CI=1.04-1.40,p=0.016).Conclusions This meta-analysis that pooled ten studies has shown that BDZ significantly increases the risk of dementia in the elderly population.The risk is higher in patients taking BDZ with a longer half-life (>20 hours) and for a longer duration (>3 years).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3988/jcn.2019.15.1.9

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 22

  1. Griffin, 2013, Ochsner J, 13, 214
  2. Gallacher, 2012, J Epidemiol Community Health, 66, 869, 10.1136/jech-2011-200314 · DOI · Paper page
  3. Wu, 2011, Am J Geriatr Psychiatry, 19, 151, 10.1097/JGP.0b013e3181e049ca · DOI
  4. Wu, 2009, Am J Geriatr Psychiatry, 17, 614, 10.1097/JGP.0b013e3181a65210 · DOI
  5. Lagnaoui, 2002, J Clin Epidemiol, 55, 314, 10.1016/S0895-4356(01)00453-X · DOI
  6. Billioti de Gage, 2012, BMJ, 345, e6231, 10.1136/bmj.e6231 · DOI · Paper page
  7. Gomm, 2016, J Alzheimers Dis, 54, 801, 10.3233/JAD-151006 · DOI · Paper page
  8. Shash, 2016, Alzheimers Dement, 12, 604, 10.1016/j.jalz.2015.10.006 · DOI · Paper page
  9. Imfeld, 2015, Drug Saf, 38, 909, 10.1007/s40264-015-0319-3 · DOI
  10. Chan, 2017, Psychogeriatrics, 17, 310, 10.1111/psyg.12239 · DOI · Paper page
  11. Begg, 1994, Biometrics, 50, 1088, 10.2307/2533446 · DOI · Paper page
  12. Golder, 2013, PLoS One, 8, e71813, 10.1371/journal.pone.0071813 · DOI
  13. Imbimbo, 2011, Curr Top Med Chem, 11, 1555, 10.2174/156802611795860942 · DOI · Paper page
  14. May, 1993, Neurosci Lett, 152, 169, 10.1016/0304-3940(93)90510-R · DOI
  15. Pariente, 2016, CNS Drugs, 30, 1, 10.1007/s40263-015-0305-4 · DOI
  16. Zhang, 2016, Alzheimer Dis Assoc Disord, 30, 113, 10.1097/WAD.0000000000000099 · DOI
  17. Taragano, 2009, J Clin Psychiatry, 70, 584, 10.4088/JCP.08m04181 · DOI · Paper page
  18. Rossat, 2011, J Nutr Health Aging, 15, 72, 10.1007/s12603-011-0015-7 · DOI · Paper page
  19. Díaz-Gutiérrez, 2017, Maturitas, 101, 17, 10.1016/j.maturitas.2017.04.002 · DOI · Paper page
  20. Fastbom, 1998, Alzheimer Dis Assoc Disord, 12, 14, 10.1097/00002093-199803000-00002 · DOI · Paper page
  21. Chen, 2012, PLoS One, 7, e49113, 10.1371/journal.pone.0049113 · DOI · Paper page
  22. Billioti de Gage, 2014, BMJ, 349, g5205, 10.1136/bmj.g5205 · DOI · Paper page

Cited by

See all 95

Metadata

Authors
He, Q., Chen, X., Wu, T., Li, L., & Fei, X.
Venue
Journal of Clinical Neurology
Published
2019
Volume
15
Issue
1
Pages
9
ISSN
  • 1738-6586 (ISSN-L)
  • 2005-5013
OpenAlex
W2904873292
Cited by
95
References
7
FWCI
2.53
Type
journal article
Language
en
Open access
diamond
Licence
creativecommons.org/licenses/by-nc/4.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.